GRAS Overview and Industry Perspectives

Slides:



Advertisements
Similar presentations
Food Advisory Committee Meeting Risk assessments and susceptible life stages and populations December 16, 2014 Rachel Osterman Associate Chief Counsel,
Advertisements

Strengthening the Medical Device Clinical Trial Enterprise
Integrating CMC Review & Inspection Industry Recommendations Joe Anisko April 24, 2003.
Dietary Supplements Public Meeting November 15, 2004 George A. Burdock, Ph.D. Diplomate, American Board of Toxicology Fellow, American.
ESTABLISHING A CO-OPERATIVE FRAMEWORK BETWEEN THE ACCREDITATION COUNCIL OF TRINIDAD AND TOBAGO (ACTT) AND PROFESSIONAL STATUTORY AND REGULATORY BODIES.
SAFA- IFAC Regional SMP Forum
Purpose of the Standards
 2011 Johns Hopkins Bloomberg School of Public Health Regulation of Tobacco Products Mitch Zeller, JD Pinney Associates.
Animal Feed GRAS Notifications Geoffrey K. Wong, M.S. Division of Animal Feeds Center for Veterinary Medicine Pet Food Institute Pet Food Institute October.
NEW DIETARY INGREDIENTS AND FOOD ADDITIVES: WHAT THEY HAVE IN COMMON A. Wes Siegner, Jr. Hyman, Phelps & McNamara, P.C th Street, N.W. Washington,
Probiotics: Safety Issues Francis B Palumbo, PhD, Esq. University of Maryland School of Pharmacy Center on Drugs & Public Policy.
Executive summary prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY RISK MANAGEMENT.
Challenges of a Harmonized Global Safety Regime Jacques Repussard Director General IRSN IAEA 2007 Scientific Forum.
Ashland Specialty Ingredients IFAC’s cGMP Audit Guide How the Food Ingredient Industry has Responded to FSMA and Food Safety Audits Priscilla Zawislak.
Prepared by: Taruna Navraksha Irfaan Shashi Food Quality & Certification.
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
1 Supplements and Other Changes to an Approved Application By: Richard J. Stec Jr., Ph.D. February 7, 2007.
Food: What Statistics Say and Don’t Say Food Consumption Tends Food Additives and How They Are Regulated.
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. THE PRACTICE OF REGULATORY INTELLIGENCE: CASE STUDIES OMICS 5 th International Pharmaceutical.
08 October 2015 M. Ammar Mehdi Introduction to Human Resource Management & SSG-16 Actions 4 th Steering Committee on Competence of Human.
United States Department of Agriculture Food Safety and Inspection Service Public Meeting on Product Labeling: Definition of the Voluntary Claim “Natural”
Council for Responsible Nutrition FDA Public Meeting on New Dietary Ingredients Annette Dickinson, Ph.D. November 15, 2004.
Module 3 Risk Analysis and its Components. Risk Analysis ● WTO SPS agreement puts emphasis on sound science ● Risk analysis = integrated mechanism to.
COMPARABILITY PROTOCOLUPDATE ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE Manufacturing Subcommittee July 20-21, 2004 Stephen Moore, Ph.D. Chemistry Team.
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
© 2009 Hogan & Hartson LLP. All rights reserved. Toward Closer Cooperation in the New Decade? FDA Issues Martin J. Hahn Hogan & Hartson, L.L.P. NABCA 17.
JMAFF (Chair of Biologicals Quality Monitoring EWG)
Regulation of Generic Animal Drugs in the United States
© 2011 Underwriters Laboratories Inc. Conformity Assessment Best Practices and Advancing GRP in EAC: The Value of Public-Private Partnerships EAC Workshop.
IADSA Scientific Forum 2009 The scientific substantiation of health claims David P. Richardson Scientific Adviser to UK Council for Responsible Nutrition.
Project: EaP countries cooperation for promoting quality assurance in higher education Maria Stratan European Institute for Political Studies of Moldova.
Carryover and Functional Use Maia M. Jack, Ph.D. Vice President, Science and Regulatory Affairs.
SELECT COMMITTEE MEETING
Stages of Research and Development
GRAS Overview and Industry Perspectives
POST APPROVAL CHANGE MANAGEMENT PROTOCOLS IN THE EUROPEAN UNION
The Association for Challenge Course Technology
Food Additives Project
Overview of FDA’s Program for Reviewing New Food Contact Substances
Dr Pascale POUKENS-RENWART Scientific Officer
EFSA Trusted science for safe food Guilhem de Sèze
CHANGE CONTROL.
ROUTES TO REGULATORY CLEARANCE FOR NEW INTERVENTION PROCESSES
Promotion to Full Professor: Regulations and Procedures
Premarket Notification 510(k) process
FDA’s IDE Decisions and Communications
Introduction to the Definition of Solid Waste Final Rule
Balancing Regulation and Innovation: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
Public Oversight of the Audit Profession David DEVLIN President
Business sector engagement and Consumer Awareness October 3rd, 2017
The Current PMA Requirements
Overview of the WTO SPS Agreement and the role of
FDA Guidance for Industry and FDA Staff Summary of Public Notification of Emerging Postmarket Medical Device Signals (“Emerging Signals”) Effective: December.
Introduction of New Technology: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
Quality Workshop The Local Council Award Scheme is a great guide for good practice in our sector and a way for councils to build confidence in their.
GMD Data Request NERC Rules of Procedure Section 1600
Structure–Feedback on Structure ED-2 and Task Force Proposals
Humanitarian Assistance
Animal Welfare EU Strategy
Pancreas Program Functional Inactivity
Competency Standards for Mediators
What Is VQIP? FDA required to establish a program to provide for the expedited review of food imported by voluntary participants. Eligibility is limited.
Response to Intervention in Illinois
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Promotion to Full Professor: Regulations and Procedures
Compounded Drugs and Lack of Premarket FDA-Approval
Internal and External Quality Assurance Systems for Cycle 3 (Doctoral) programmes "PROMOTING INTERNATIONALIZATION OF RESEARCH THROUGH ESTABLISHMENT AND.
Ontario Presentation to the NEB Modernization Expert Panel
Radiopharmaceutical Production
Presentation transcript:

GRAS Overview and Industry Perspectives Carl Bao CP Kelco International Food Additives Council Food Additives: A Global Perspective on Safety Evaluation and Use Jakarta, Indonesia September 15, 2016

Presentation Overview U.S. Food Additive and GRAS Regulatory Background U.S. Food Additive Petition Process U.S. GRAS Process GRAS Determinations GRAS Notifications Value of GRAS Ensuring a Robust GRAS Process Conclusion

Safety Evaluation of Food Ingredients in the U.S. According to the U.S. FDA, the term safe means that “there is reasonable certainty in the minds of competent scientists that a substance is not harmful under the intended conditions of use.” The term food additive refers to “any substance that the intended use of which results or may reasonably be expected to result -- directly or indirectly -- in its becoming a component or otherwise affecting the characteristics of any food.” A substance is Generally Recognized as Safe or GRAS if it is “generally recognized, among qualified experts, as having been adequately shown to be safe under the conditions of its intended use, or unless the substance is otherwise excluded from the definition of a food additive.”

Food Additives and GRAS Background In the U.S., substances are added to food through: Food Additive Petition OR GRAS Determination GRAS Notification

Food Additive Petition Process Public rulemaking process enhances transparency For new substances, substances not considered GRAS, and/or substances without a long history of safe use Petitioner develops a petition and submits to U.S. FDA with all supporting toxicological data (publicly and privately available) Burden to determine safety primarily rests with U.S. FDA After U.S. FDA review, a notice appears in the Federal Register for public review/comment; specifies the conditions of use Once approved, food additives appears in the Code of Federal Regulations (21 CFR Part 172) Slow Process: take years

GRAS Process GRAS determinations require scientific evidence of equivalent quantity and quality as that needed for a Food Additive Petition All data to support the GRAS determination must be publicly available GRAS determinations “may be based only on the views of experts qualified by scientific training and experience to evaluate the safety of substances directly or indirectly added to food.” (21 CFR 170.30) Burden to prove safety primarily rests with the company More Timely, less Burdensome on U.S. FDA, promotes innovation and allows for faster time to market Unique to the U.S.

GRAS Determinations Company takes GRAS position based on common knowledge and general acceptance among qualified experts that a substance is safe for its intended use All data to support independent determination must be publicly available Company is not required to inform FDA of its GRAS determination (i.e., “independent determination”) GRAS determinations require scientific evidence of equivalent quantity and quality as that needed for a Food Additive Petition IFAC member companies typically use an expert panel for safety determination

GRAS Notifications Additional step companies may voluntarily take to enhance transparency Company informs U.S. FDA of its GRAS determination and provides all supporting information to FDA Most information to establish GRAS status must be publicly available Does not require public rulemaking process Manufacturer may meet with FDA prior to notification to review dossier and ask questions (FDA encourages) FDA reviews notification and responds with a letter stating: FDA has no questions The notifier has not provided a basis that the substance is GRAS, FDA has ceased to review the notification at the request of the notifier U.S. GRAS Notice Inventory lists substances that have been notified since 1998; some GRAS substances are listed in 21 CFR Part 184

Additional GRAS Considerations U.S. FDA recently completed rulemaking on GRAS rule-impacts self-GRAS and GRAS notifications FDA’s final rule clarifies and strengthens the oversight by better explaining how general recognition of safety is determined IFAC believes the GRAS process works well for industry and FDA; IFAC is supportive of the final rule IFAC not aware of any safety concerns that have arisen from this process IFAC member companies typically use an expert panel for safety determination IFAC developed a GRAS Best Practices Guide to demonstrate industry expectations for making GRAS determinations

Food Additive Petition vs. GRAS Processes Level of Evidence Safety Evidence in Public Domain? Public Rulemaking Process? Who Makes Safety Determination? Timing Food Additive Petition Same Not Required Yes US FDA Years GRAS Determination (not notified) Required No Company uses independent experts to make safety determination Weeks/ Months GRAS Notification Experts make determination; FDA Issues “No Questions” Letter Months

Value of the GRAS Process Targeted Use of Limited U.S. FDA Resources Burden to prove safety rests primarily with industry Shorter review times and time to market Takes advantage of common knowledge element and history of safe use 1958: FD&C Act Defines “Food Additive” (includes GRAS exclusion) Early 1970s: FDA establishes formal GRAS-affirmation petition process 1996: Backlog of food additive petitions & GRAS affirmation petitions led to calls for reform by President Clinton and the industry December 2015: FDA has filed nearly 600 GRAS notices (averaging 30 notices/year) FDA Responses (as of September 2015) - 559 responses issued - 81% FDA has no questions - 3% Insufficient basis - 16% Notifier stops process Reference: Dr. Toni Mattia, US FDA

Average time for market clearance (excludes dossier preparation time) Supports Innovation and Product Development Market-driven innovation spurs demand for substances with functional/health benefits and/or desired technological functionality Facilitates faster market introduction of new and innovative products to meet consumer demand for convenient and “healthier” options Ensures safety while fostering innovation Value of the GRAS Process Average time for market clearance (excludes dossier preparation time) Food additive petition 14-18 months (expedited i.e., enhances food safety) >18 months GRAS notification (FDA review only) ~ 180 days (6 months) GRAS expert panel ~ 1 month

“The Making of a GRAS Substance” - Ensuring a robust GRAS process Identification and Characterization of the Substance Manufacturing Process Unit operations Raw Materials Chemically Defined vs. Natural Complexes Stability Reaction within food matrix Breakdown of products

“The Making of a GRAS Substance” - Ensuring a robust GRAS process Data to Assess Safety & Support a GRAS Claim Determining Safe Levels of Intake Literature search for all relevant information Fair & balanced Scope Post-launch product stewardship Monitor & re-evaluate Estimating Daily Intake/Exposure Market intelligence – similar competitive products Existing history of use & use levels Background levels from natural sources

“The Making of a GRAS Substance” - Ensuring a robust GRAS process GRAS Expert Panel Training and Experience Qualification Standard Independent Advisor vs. expert panel member Conflict of interest assessment SOP “FDA would normally look for such qualifications as training and experience in the relevant scientific disciplines, professional positions held, name recognition by fellow members of the scientific community and publications in respected journals in the field.“ Reference: Rulis, A and Levitt, J. FDA’S food ingredient approval process: Safety assurance based on scientific assessment. Regulatory Toxicology and Pharmacology. 2009 Feb; 53(1):20-31.

Concluding Remarks Substances may be added to food in the U.S. through a Food Additive Petition or following the GRAS process. Food Additive Petitions require public rulemaking; GRAS determinations do not. GRAS determinations require scientific evidence of equivalent quantity and quality as that needed for a Food Additive Petition. The GRAS process is well established, brings value and works well. The food ingredient industry has a vested interest in ensuring a robust and well accepted food system, including the food additive and GRAS processes. The food industry has been and must continue to be diligent to ensure ingredients are safe, through the application of appropriate best practices and sound scientific principles. The food ingredient industry embraces initiatives to strengthen food safety that are based on sound science and desires to contribute to the discussion by sharing industry specific expert knowledge and concerns.

Helpful URLs IFAC website – foodingredientfacts.org FDA Food Additive Petition process – http://www.fda.gov/Food/IngredientsPackagingLabeling/FoodAdditivesIngredients/ Food Additives Permitted for Direct Addition to Food for Human Consumption – https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=172 FDA Generally Recognized as Safe (GRAS) – http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/default.htm How to Submit a GRAS Notice – http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/ucm083062.htm U.S. GRAS Notice Inventory – http://www.accessdata.fda.gov/scripts/fdcc/?set=GRASNotices

International Food Additives Council Questions? Thank you! Carl Bao Asia Pacific Regulatory Affairs Manager CP Kelco Carl.Bao@cpkelco.com International Food Additives Council 750 National Press Building Washington, DC USA foodingredientfacts.org